Biogen Idec, Inc. (BIIB) Tops Q3 Adj-EPS by 8c
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $199.71 +1.59%
Revenue Growth %: -6.5%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 219.4M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -6.5%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 219.4M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q3 EPS of $1.61, ex-items, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.27 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
- Jabil beats consensus estimates but shares dip
- John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook
Create E-mail Alert Related Categories
Earnings, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
